尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Sensenig Bethany, Director. Director active across 3 companies, notably Supernus Pharmaceuticals, INC.. Aggregated, 6 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €205k. History available since 21 April 2023. The latest transaction was filed on 16 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Bethany Sensenig is a Board Member at Supernus Pharmaceuticals, Inc. She brings expertise in corporate governance and strategy. Her role involves overseeing operations and contributing to strategic decision-making within the company. Through her experience, she plays a key role in shaping governance policies and practices, ensuring compliance and organizational effectiveness.